Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Profit After Tax (2018 - 2025)

AVITA Medical's Profit After Tax history spans 8 years, with the latest figure at -$11.6 million for Q4 2025.

  • For Q4 2025, Profit After Tax changed 0.28% year-over-year to -$11.6 million; the TTM value through Dec 2025 reached -$48.6 million, up 21.44%, while the annual FY2025 figure was -$48.6 million, 21.44% up from the prior year.
  • Profit After Tax reached -$11.6 million in Q4 2025 per RCEL's latest filing, up from -$13.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$4.7 million in Q2 2021 to a low of -$18.7 million in Q1 2024.
  • Average Profit After Tax over 5 years is -$10.0 million, with a median of -$9.5 million recorded in 2022.
  • Peak YoY movement for Profit After Tax: soared 63.47% in 2021, then tumbled 102.36% in 2024.
  • A 5-year view of Profit After Tax shows it stood at -$5.9 million in 2021, then increased by 10.0% to -$5.4 million in 2022, then crashed by 31.98% to -$7.1 million in 2023, then crashed by 64.03% to -$11.6 million in 2024, then decreased by 0.28% to -$11.6 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Profit After Tax are -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025).